[account_shop_links]
Electronic Detailing vs. In-person Detailing (US)
$4,900.00 – $9,800.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
This report provides a head-to-head comparison US physicians’ preferences for sales rep interactions and electronic detailing (“eDetailing”). The report provides insight into physicians’ informational needs, the volume and time spent during those interactions, and the value and outcomes placed on those interactions.
All data are reported in aggregate and across four therapeutic specialties (Allergy & Immunology, Cardiology, Family Medicine, and Oncology).
What you will learn:
- Prescribers’ needs and expectations for product detail sessions and the degree to which those needs are met in both electronic and in-person detail sessions
- Quantify the volume of eDetail and in-person sessions they experience per week and their desired volume – the number of eDetail sessions they believe is reasonable
- Measure the overall value and satisfaction with both in-person and electronic details.
- Prescribers’ perspectives on the types of products that are most and least appropriate for an eDetail environment
Therapeutic Areas Analyzed:
All metrics are reported and analyzed across the following therapeutic areas
- Allergy & Immunology
- Cardiology
- Family Medicine
- Oncology
Report Contents:
- Detailing Information Needs – This section outlines and ranks in order of importance the information needs that prescribers have for detail sessions – regardless of whether in-person or electronic.
- Detailing Volume and Time: In-person vs. Electronic – Here we establish – by therapeutic specialization – how many in-person and how many electronic detail sessions the prescribers experience per week; how many they believe is reasonable; how much time they dedicate to each; and how the volume and time have changed over the past 2 years.
- Detailing Outcomes – In the final analysis section of the report we present – by therapeutic specialization – prescribers’ assessments of a number of outcome variables for both in-person and electronic detail sessions.
- Study Data – As always, ISR provides a section of charts and graphs that outline the responses to every question asked in the research. Spend some time in this section to formulate additional insights.
